Any analyst follow this stock with some price target?
New here not sure what causes the big drop and law issue. On the one hand chart looks like turn around, on the other hand, market is too high plus end of year tax selling is near.
Appreciate any comments
Yeah, $20 soon.
Only this will make people feel better ( for a while )
Guess more important question about phase II is what is the control group , same as phase III? , if yes, % lived more than five months? With that information, we may have better guess. IMO
talk about exact price change 0.008, if you trade goog you are right no big deal, here it means almost 6%. So one day down almost 6% and you have no feeling.
Guess you are indeed a bad trader.
Bear trap or bull trap?
I tomorrow close at new high, some thing for real is behind it , otherwise it could retest .49-.50. IMO
Yeah, after hundred cases like the " the same thing", finally there is DNDN and now you wan to bet rest " same thing"
Need watch more so can learn better
Then what about the rest of this year?
Any reason to go high? Or ask yourself; do you want to add more from now to end of year?
On the other hand, market at the top and if down, I see first support at $2.6-2.7 and next one around $2.3
Biggest does not necessary mean it won't get bigger. Without any meaningful catalyst all major index with significant gain year to date, guess what will happen for tax selling?
Remember all the waiting and boring time when share price around .41-.43?
Finally it breaks out and trend is clearly up.
MACK; similar story like MSTX, after 2nd offering at $5 PPS dropped to $4 and then further down to 3+.
now it stars to recovery and the CURREN chart ( share price, MACD, MFI etc) looks very very similar to MSTX chart 1-2 week ago, right before broke .50.
Maybe two stocks same MM?
Any update about Oct 2 presentation? If any positive hint can be found, this stock is due for a bounce; tech indicators show oversold for quite period of time already. Interestingly MACD starts turn up.
also when will we hear about results from Phase II/III CANVAS trial for CVac in conjunction with chemotherapy? That has more chance show positive results, IMO